Bone Biologics Corp (BBLG): Price and Financial Metrics


Bone Biologics Corp (BBLG): $1.30

0.08 (+6.56%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BBLG Stock Price Chart Interactive Chart >

Price chart for BBLG

BBLG Price/Volume Stats

Current price $1.30 52-week high $7.12
Prev. close $1.22 52-week low $1.13
Day low $1.21 Volume 3,510
Day high $1.30 Avg. volume 755,415
50-day MA $1.57 Dividend yield N/A
200-day MA $0.00 Market Cap 13.46M

Bone Biologics Corp (BBLG) Company Bio


Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.


BBLG Latest News Stream


Event/Time News Detail
Loading, please wait...

BBLG Latest Social Stream


Loading social stream, please wait...

View Full BBLG Social Stream

Latest BBLG News From Around the Web

Below are the latest news stories about Bone Biologics Corp that investors may wish to consider to help them evaluate BBLG as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Grab a cup of coffee and get ready for another busy day of trading as we start with the biggest pre-market stock movers for Tuesday!

William White on InvestorPlace | January 11, 2022

Pacific Biosciences of California, TechnipFMC among premarket losers'' pack

Huadi International Group (HUDI) -16%.Bone Biologics (BBLG) -12%.Reviva Pharmaceuticals (RVPH) -10%.Pacific Biosciences of California PACB -9% after reports lower than expected prelim

Seeking Alpha | January 11, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Welcome back, trader!

William White on InvestorPlace | January 10, 2022

BBLG Stock Alert: 7 Things to Know as Bone Biologics Skyrockets Today

Today, investors in Bone Biologics and BBLG stock are seeing some serious gains as investors dive into niche small caps.

Chris MacDonald on InvestorPlace | January 10, 2022

Why Are Bone Biologics Shares Surging On Monday?

Newly listed Bone Biologics Corporation (NASDAQ: BBLG ) shares are surging after the Company announced to present at the H.C. Wainwright BioConnect Virtual Conference. Bone Biologics is focused on regenerative medicine for bone. The Company is working on the Nell-1 protein, a bone graft substitute product on bone regeneration in spinal fusion, and has rights to trauma and osteoporosis applications. Recombinant NELL-1 is purified and mixed Full story available on Benzinga.com

Benzinga | January 10, 2022

Read More 'BBLG' Stories Here

BBLG Price Returns

1-mo -12.16%
3-mo -54.23%
6-mo -62.10%
1-year N/A
3-year N/A
5-year N/A
YTD -63.07%
2021 N/A
2020 0.00%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4162 seconds.